Description: Kane Biotech Inc., a biotechnology company, researches, develops, and commercializes technologies and products that prevent and remove microbial biofilms worldwide. It develops wound care solutions under the DispersinB trademark; medical device coatings under the Aledex trademark; shampoo for dogs, cats, and horses under the Alosera trademark; and pet oral care solutions under the StrixNB and bluestem trademarks. The company was founded in 2001 and is based in Winnipeg, Canada.
Home Page: kanebiotech.com
100 Innovation Drive
Winnipeg,
MB
R3T 6G2
Canada
Phone:
204-453-1301
Officers
| Name | Title |
|---|---|
| Mr. Marc Edwards | President, CEO & Director |
| Mr. Ray Dupuis | Chief Financial Officer |
| Dr. Robert B. Huizinga CNeph(C), M.Sc., MSc(Epi), Ph.D., R.N., RN NNC | Executive Chairman & Member of Scientific Advisory Board |
| Dr. Gregory S. Schultz Ph.D. | Chief Scientific Officer & Member of Scientific Advisory Board |
| Lorne Gorber | Investor Relations |
| Ms. Wendy Nachtigall | Director of Marketing |
| Ms. Lori Christofalos | Chief Quality Officer |
| Nicole Sendey | Investor Relations Adviser |
Exchange: OTCQB
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 2 |
| Price-to-Book MRQ: | 102.6115 |
| Price-to-Sales TTM: | 7.4506 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |